Contribution of NOD2 to lung inflammation during Staphylococcus aureus-induced pneumonia

Ronan Kapetanovic1, Gregory Jouvion, Catherine Fitting

  • 1Institut Pasteur, Unité Cytokines & Inflammation, Département Infection et épidémiologie, 28 rue du Dr Roux, F-75015 Paris, France.

Insights

NOD2 (nucleotide-binding oligomerization domain-containing protein 2) absence in mice reduced lung inflammation and improved recovery from Staphylococcus aureus pneumonia. This suggests NOD2 contributes to, rather than protects against, pneumonia-induced inflammation.

Area of Science:

  • Immunology
  • Microbiology
  • Pulmonary Medicine

Background:

  • Staphylococcus aureus is a common cause of ICU-acquired infections like pneumonia.
  • The role of NOD2 (nucleotide-binding oligomerization domain-containing protein 2) in S. aureus pneumonia is not fully understood.

Purpose of the Study:

  • To investigate the role of NOD2 in the host response to Staphylococcus aureus-induced pneumonia.

Main Methods:

  • Comparison of wild-type and Nod2-/- mice infected with S. aureus.
  • Analysis of weight loss, recovery, lung inflammation, cytokine levels, neutrophil recruitment, and lung histology.

Main Results:

  • Nod2-/- mice exhibited less weight loss and faster recovery.
  • Reduced lung inflammation, lower cytokine levels in broncho-alveolar lavage fluid, and decreased neutrophil infiltration were observed in Nod2-/- mice.
  • Histological analysis showed less severe lung lesions in Nod2-/- mice.

Conclusions:

  • NOD2 is not essential for fighting S. aureus pneumonia but contributes to the inflammatory response.
  • Absence of NOD2 resulted in diminished lung inflammation and improved animal recovery, indicating a beneficial role in this context.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...